Browse EX-10 agreements

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made on the 17th day of September 2026 by and between Vestis Corporation, a Delaware corporation (the “Company”), and Russell Tiejema (“Executive”). The Company and Executive are sometimes referred to individually as a **“Party” **and collectively, the “Parties.”

W I T N E S SE T H

WHEREAS, the Company desires to employ Executive and Executive desires to be employed by the Company, all on the terms and conditions set forth herein.

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth below, it is hereby covenanted and agreed by the Company and Executive as follows, all effective as of the Effective Date:

…

**THE EXCHANGE CONTEMPLATED HEREIN IS INTENDED TO COMPORT WITH THE REQUIREMENTS OF SECTION 3(a)(9) OF THE SECURITIES ACT OF 1933, AS AMENDED. **

***EXCHANGE AGREEMENT ***

This Exchange Agreement (this “Agreement”) is entered into as of September 25, 2026 (the “Effective Date”) by and between Streeterville Capital, LLC, a Utah limited liablity company (“Lender”), and Jaguar Health, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Original Note (as defined below).

A. Company previously sold and issued to Investor that certain Secured Promissory Note dated January 19, 2021 (the “Original Note”) pursuant to that certain Note Purchase Agreement dated January 19, 2021 (the “Purchase Agreement,” and together with the Original Note and all other documents entered into in conjunction therewith, the “Transaction Documents”).

…

---

Exhibit 10.1

MEMBERSHIP INTEREST PURCHASE AGREEMENT

by and among

DRUB LLC,

as Buyer,

DRUBIT LLC,

as the Company,

DRUBIT HOLDINGS LLC,

as Seller,

 solely for the limited purposes set forth herein,

US DEVELOPMENT GROUP LLC,

as USDG, and

solely for the purposes of Section 5.4 and Section 6.11,

FTAI ENERGY PARTNERS LLC,

as Buyer Parent

Dated as of September 27, 2026

i

---

TABLE OF CONTENTS

			Page

…

** **

** **

Microbot Medical® Highlights Growth Strategy

** **

User Survey Demonstrates High Satisfaction of the LIBERTY System

* *

Expansion of Sales Footprint Expands to Western U.S. as Company Secures First California Customer

* *

HINGHAM, Mass., September 25, 2026 – Microbot Medical Inc. (Nasdaq: MBOT), announced that it highlighted the continuation of its commercial and growth strategy during an analyst meeting held in New York City on Thursday, September 24, 2026. The Company also highlighted select results from a user survey, available on the Company’s website, conveying high satisfaction with the system.

Key Topics Discussed:

…

BOARD RIGHTS AGREEMENT

This Board Rights Agreement (this “Agreement”) is entered into as of September 23, 2026 (the “Effective Date”), by and between Celularity Inc., a Delaware corporation (the “Company”), and the Philip & Daniele Barach Family Trust, a trust formed under the laws of California (the “Trust”; the Company and the Trust are referred to herein individually as a “Party” and collectively as the “Parties”).

WITNESSETH:

…

SECURITIES PURCHASE AGREEMENT

** **

THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of September 23, 2026, by and among Celularity Inc., a Delaware corporation (and together with all of its current and future, direct and/or indirect, wholly owned and/or partially owned Subsidiaries, collectively, the “Company”), and the one or more persons and entities identified on the signature pages hereto and on the Schedule of Purchasers attached hereto as Schedule 1, each individually, a “Purchaser,” and collectively, the “Purchasers.”

RECITALS

A. The Company and the Purchasers are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act (as defined below), and/or Rule 506(b) of Regulation D (“Regulation D”) as promulgated by the SEC (as defined below).

…

SECURITY AGREEMENT

This SECURITY AGREEMENT, dated as of September 23, 2026 (as amended, supplemented or otherwise modified from time to time in accordance with the provisions hereof, this “Agreement”), made by and among Celularity Inc. (the “Company” and each of the Company’s subsidiaries named on the signature pages hereto (each, a “Grantor” and collectively, the “Grantors”) and Philip Barach, as collateral agent (in such capacity, the “Collateral Agent”), for the benefit of the Purchasers (as defined below) party to the Purchase Agreement (as defined below) from time to time, together with their respective successors, endorsees, transferees and permitted assigns (collectively, the “Secured Party”).

W I T N E S S E T H:

…

INTERCREDITOR AGREEMENT

INTERCREDITOR AGREEMENT (the “Agreement”), dated as of September 23, 2026, by and among Celularity Inc., a Delaware corporation (the “Company”), the purchasers identified on the signature pages hereto (each, a “Purchaser” and collectively, the “Purchasers”), and Philip Barach, as collateral agent (the “Collateral Agent”).

WITNESSETH:

WHEREAS, the Company and the Purchasers have entered into that certain Securities Purchase Agreement, dated as of September 23, 2026 (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”), pursuant to which the Company has agreed to issue and sell to the Purchasers Senior Secured Convertible Promissory Notes in an aggregate principal amount of up to $25,000,000 (each, a “Note” and collectively, the “Notes”);

…

SETTLEMENT, RELEASE AND TERMINATION AGREEMENT

This SETTLEMENT, RELEASE AND TERMINATION AGREEMENT (this “Agreement”) is entered into as of September 18, 2026 (the “Effective Date”), by and between Celularity Inc., a Delaware corporation (the “Company”), and Helena Global Investment Opportunities 1 Ltd, a Cayman Islands exempted company (“Helena”). The Company and Helena are each a “Party” and collectively the “Parties.”

RECITALS

…

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is made and entered into as of September 23, 2026, between Celularity Inc., a Delaware corporation (the “Company”), and the one or more purchasers identified on the signature pages hereto and on the Schedule of Purchasers attached to the Purchase Agreement (each individually, a “Purchaser,” and collectively, the “Purchasers”).

WHEREAS, the Company will issue to the Holders (as defined below) up to $25,000,000 in aggregate principal amount of convertible notes (the “Notes”) of the Company pursuant to that certain Securities Purchase Agreement dated as of September 23, 2026, by and among the Company and the Purchasers party thereto (the “Purchase Agreement”); and

…

CREDIT AGREEMENT

dated as of

September 25, 2026

among

STEPAN COMPANY

as Company

The Foreign Subsidiary Borrowers Party Hereto

The Lenders Party Hereto

and

JPMORGAN CHASE BANK, N.A.

as Administrative Agent

and

BANK OF AMERICA, N.A.

as Syndication Agent

and

CITIBANK, N.A.,

PNC BANK, NATIONAL ASSOCIATION

and

U.S. BANK NATIONAL ASSOCIATION

as Co-Documentation Agents

JPMORGAN CHASE BANK, N.A.

and

BofA SECURITIES, INC.

as Joint Lead Arrangers and Joint Bookrunners

---

TABLE OF CONTENTS

…

Prototype Project Agreement

SAMDIB Project acCELLerate

Attachment 0001

23 September 2026

Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Omissions are designated by [***].

Prototype Project Agreement

FOR

Strengthening America’s Manufacturing and Defense Industrial Base (SAMDIB)

Project acCELLerate: Domestic Production of Silicon Anode High Energy Density Lithium-Ion Batteries for Small UAS Applications

BETWEEN

the United States of America

AND

Amprius Technologies, Inc.

UNDER

“Cornerstone” Other Transaction Authority (OTA)

Agreement Number: CS-24-1801 Invoicing: W519TC-26-9-A416

Agreement Type: Fixed Based

Total Amount: $74,793,173.11

Task Table:

…